JS

Jalindar Shankar Kadam

Active Director Director DIN 10753537
DIN 10753537 First appointment Aug 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2024
Shareholding value •••• Premium profile

About Jalindar Shankar Kadam

Data last updated:

Jalindar Shankar Kadam is a Director at Shalimed Pharmaceuticals Private Limited (since 2024). The company operates in Pharma. Shalimed Pharmaceuticals Private Limited reported revenue of ₹20.6 Lakh (FY 2025).

DIN 10753537
Primary Designation Director
Industry Pharma
First Appointment 26 Aug 2024
Oldest Company Age 3 yrs
Largest company Shalimed Pharmaceuticals Private Limited · ₹20.6 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 Aug 20242023₹20.6 Lakh (FY 2025)Active

Board colleagues of Jalindar Shankar Kadam

Directorship timeline

Open interactive timeline →
Shalimed Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Jalindar Shankar Kadam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jalindar Shankar Kadam

Jalindar Shankar Kadam currently holds 1 directorship: Shalimed Pharmaceuticals Private Limited (Director, since 26 Aug 2024, revenue ₹20.6 Lakh (FY 2025)).

Jalindar Shankar Kadam was first appointed on 26 Aug 2024 as Director at Shalimed Pharmaceuticals Private Limited.

The current boards of Jalindar Shankar Kadam's companies include Tushar Ankushrao Deshmukh (Shalimed Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available